Hemophilia Outreach Center

What Hemophilia Outreach Center does

Hemophilia Outreach Center (HOC) is a federally recognized Hemophilia Treatment Center headquartered in Green Bay, Wisconsin, providing comprehensive, multidisciplinary care for individuals with bleeding disorders. Founded in 1977 (with roots in a 1974 home-training program) and operating continuously for over 47 years, HOC serves hundreds of families across 35+ Wisconsin counties and Michigan's Upper Peninsula, with a second clinic opened in Wausau, Wisconsin in March 2022. The organization's patient base spans hemophilia A and B, von Willebrand disease, women and girls with heavy menstrual bleeding, and family members of affected patients.

HOC's core offering is an integrated care model delivered under one roof that combines Primary Care, Behavioral Health, Nutrition, Physical Therapy, Dental, Genetic Counseling, Social Work, and a specialized Heavy Menstrual Bleeding Clinic, supplemented by 24/7 on-call coverage and telehealth/virtual visits. The center is among the first in the world to administer FDA-approved gene therapies for hemophilia B (HEMGENIX, approved November 2022; first Wisconsin patient treated June 2023) and hemophilia A (Roctavian, approved June 2023). Beyond clinical services, HOC operates a community and research ecosystem including the "Beyond the Bleeds" podcast, Camp Klotty Pine for children ages 7-15, a mentorship program, the Winter Education Program, and participation in the ATHNdataset Registry, Community Voices in Research, and vWD Connect Registry. Strategic partnerships span Green Bay Oncology (medical directorship), Paramount Physical Therapy, the CDC, ATHN, the Great Lakes Hemophilia Foundation, Versiti Blood Center, NWTC, and the BD SUMHAC advocacy coalition.

HOC generates revenue by billing insurance providers, Medicare, Medicaid, and patients directly for clinical services, with pricing not publicly disclosed. As a federally recognized HTC and research-contributing site, the organization benefits from CDC and ATHN-supported infrastructure. Jamison Buxton serves as CEO; Andrea Buxton is Clinical Director; Dr. Matthew Ryan is Medical Director. The organization is privately held with no disclosed parent company, funding rounds, or investor base, and operates from two Wisconsin clinic sites.

Name

Hemophilia Outreach Center

Legal name

Hemophilia Outreach Center

Website

https://hemophiliaoutreach.org

Company type

Private

Founded year

1974

Operating status

Operating

Headcount range

11–50 employees

Short description

Hemophilia Outreach Center is a federally recognized Hemophilia Treatment Center in Green Bay, Wisconsin, providing comprehensive multidisciplinary care for individuals with hemophilia, von Willebrand disease, and related bleeding disorders across Wisconsin and Michigan's Upper Peninsula.

Ownership category

akta.pro rank

Product category

Specialty Bleeding Disorder Healthcare Services

NAICS

Other Ambulatory Health Care Services (6219), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro industry

PRIMARYHLAKAFAA

Medical Hematology (Benign Hematology)

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAFABAF

Infusion Therapy Centers (Outpatient)

Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers

SECONDARYHLAFALAG

Infusion & Home Infusion Pharmacy Services

Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

Keywords

• Bleeding disorder care
• Hemophilia treatment center
• Multidisciplinary hematology services
• Genetic counseling services
• Physical therapy rehabilitation

Headquarters

HQ city

Green Bay

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Healthcare Services Billing: Revenue generated through billing insurance providers, Medicare, Medicaid, and patients directly for comprehensive medical care services including consultations, treatments, infusions, and procedures

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Hemophilia Outreach Center provides comprehensive, multidisciplinary medical care for individuals with bleeding disorders (hemophilia A, hemophilia B, von Willebrand disease, and related conditions). Services span primary care, behavioral health, nutrition, physical therapy, dental, genetic counseling, social work, and a specialized heavy menstrual bleeding clinic, supported by 24/7 on-call coverage and administration of advanced treatments including gene therapy. Care is delivered through two Wisconsin clinic locations (Green Bay and Wausau) with telehealth capabilities and physician referrals.

Product overview

Hemophilia Outreach Center (HOC) is a federally recognized Hemophilia Treatment Center providing comprehensive, multidisciplinary care for individuals with bleeding disorders. Founded in 1977 and serving Wisconsin and Michigan for over 47 years, HOC offers a unified care model combining Primary Care, Behavioral Health, Nutrition Services, Physical Therapy, Dental, Genetic Counseling, Social Work, and specialized Heavy Menstrual Bleeding clinics. The organization also provides 24/7 on-call coverage, operates community programs including the Beyond the Bleeds podcast, Camp Klotty Pine summer camp, and a Mentorship Program. HOC maintains active research participation through the ATHNdataset Registry, Community Voices in Research, and vWD Connect Registry. HOC made history by being among the first treatment centers globally to administer FDA-approved gene therapies (HEMGENIX for hemophilia B and Roctavian for hemophilia A).

Differentiator

Problem solved

Functional benefit

Brands

• Beyond the Bleeds: Podcast series exploring life with hemophilia, von Willebrand disease, and other rare conditions.

Products and services

• Primary Care Comprehensive primary care services establishing a medical home for patients with bleeding disorders, reducing bleeding risks during routine medical procedures and consolidating care across fewer locations. Targeted at individuals with hemophilia A, hemophilia B, von Willebrand disease, and related bleeding disorders in Wisconsin and Michigan.
• Behavioral Health Mental health and emotional support services led by a licensed clinical social worker, providing supportive therapy tailored to the needs of people with bleeding disorders and their families. Targeted at bleeding disorder patients and family members across Wisconsin and Michigan.
• Nutritionist Services
• Physical Therapy
• Dental Services
• Genetic Counseling
• Social Work
• Heavy Menstrual Bleeding Clinic
• 24/7 On-Call Medical Coverage Round-the-clock on-call clinical coverage ensuring patients can reach a provider anytime for urgent concerns, appointment changes, and medication requests. Transitioned to On Call Central service in January 2025.
• Gene Therapy Services Specialized gene therapy administration for hemophilia B (HEMGENIX) and hemophilia A (Roctavian), including comprehensive preparation, infusion, and post-treatment monitoring for patients across Wisconsin and Michigan.

Quantifiable outcome

• Hundreds of families served across Wisconsin and Michigan
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Green Bay OncologycoreStrategic or Co-development PartnerPartnership between hematology/oncology specialists and HOC for coordinated care of patients with bleeding disorders. Dr. Matthew Ryan serves as HOC Medical Director while practicing at Green Bay Oncology, enabling seamless collaboration for complex cases and expanding access to specialized care in Wisconsin and Northern Michigan communities.
• Paramount Physical TherapycoreStrategic or Co-development PartnerCollaboration with Paramount Physical Therapy to provide specialized physical therapy services supporting joint health, mobility, and injury prevention for bleeding disorder patients. Partnership emphasizes long-term wellness, education, and prevention over reactive treatment models.
• American Thrombosis and Hemostasis Network (ATHN)coreStrategic or Co-development PartnerNonprofit organization dedicated to improving lives of people with bleeding and clotting disorders through technology, data security, and research. HOC works with ATHN on the ATHNdataset Registry, the largest U.S. blood disorders real-world dataset, contributing to national research efforts.
• Centers for Disease Control and Prevention (CDC)coreStrategic or Co-development PartnerFederal partnership as a federally recognized Hemophilia Treatment Center, working with CDC on surveillance, research initiatives, and improving treatment outcomes for the bleeding disorders community.
• Great Lakes Hemophilia FoundationcoreStrategic or Co-development PartnerCollaborative partnership with the Great Lakes Hemophilia Foundation for community support, education, and advocacy. Co-hosts Wisconsin Bleeding Disorders Conference and supports Camp Klotty Pine for children with bleeding disorders ages 7-15.
• Northeast Wisconsin Technical College (NWTC)minorStrategic or Co-development PartnerEducational partnership with NWTC's nursing program to provide bleeding disorder education and training for nursing students, helping bridge gaps in specialized nursing care for bleeding disorders.
• Bleeding Disorder, Substance Use and Mental Health Access Coalition (BD SUMHAC)minorStrategic or Co-development PartnerHOC participates in BD SUMHAC, a national coalition advocating for equal access to mental health and substance use treatment for people with bleeding disorders, addressing discrimination in healthcare settings.

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Indiana Hemophilia & Thrombosis Center: Federally recognized Hemophilia Treatment Center providing comprehensive multidisciplinary care for bleeding and clotting disorders across Indiana. Most structurally comparable U.S. HTC peer to HOC in terms of integrated service model, regional reach, and federally recognized status.
• Bleeding & Clotting Disorders Institute: Specialty treatment center in Peoria, IL providing comprehensive care for bleeding and clotting disorders across Illinois. Comparable to HOC as a regional HTC with multidisciplinary services and community education programs.
• Yale Hemophilia Treatment Center: Academic-based federally recognized HTC offering comprehensive care for hemophilia and bleeding disorders. Comparable care model (multidisciplinary, gene therapy capable) though embedded in a larger academic medical system.
• Gulf States Hemophilia & Thrombosis Center: Federally recognized HTC providing comprehensive bleeding disorder care across the Gulf States region. Comparable regional HTC operating model with multidisciplinary services.
• Children's Hospital Los Angeles Hemophilia Center: Pediatric-focused HTC within a major children's hospital providing comprehensive bleeding disorder care including gene therapy administration. Comparable specialty scope though embedded in a larger hospital system.

Broad incumbents

• Versiti Blood Center: Large blood center operator providing hematology services, research, and specialty diagnostics for bleeding and clotting disorders. Active HOC collaborator (Beyond the Bleeds podcast partner); broader regional/national scope than HOC.

Others

• American Thrombosis and Hemostasis Network (ATHN): Nonprofit network supporting HTCs nationwide through data infrastructure (ATHNdataset Registry) and research coordination. Active HOC partner; comparable only as an ecosystem enabler, not a direct care competitor.
• National Bleeding Disorders Foundation: National advocacy and education organization for the bleeding disorders community. HOC partners with NBDF on the Community Voices in Research registry; comparable as a community/advocacy counterpart rather than a care provider.
• Roctavian / BioMarin Pharmaceutical: Manufacturer of Roctavian (first FDA-approved hemophilia A gene therapy, June 2023). HOC administered this therapy; relevant industry counterpart that supplies treatment but does not compete in direct patient care.

Regional players

• Great Lakes Hemophilia Foundation: Regional nonprofit serving the bleeding disorders community in the Great Lakes region. Co-hosts Wisconsin Bleeding Disorders Conference and Camp Klotty Pine with HOC; comparable as a regional community/advocacy counterpart.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/hoc_htc
• YouTubeyoutube.com/channel/UC6Kxi945WDauQDMzMLOcUbA
• Facebookfacebook.com/profile.php
• Instagraminstagram.com/hemophiliaoutreachcenter

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hemophilia Outreach Center